Protagonist Therapeutics Inc. trailing returns
Protagonist Therapeutics Inc.'s 10-year return is +19.6% a year (CAGR) (+500.0% cumulative). How Protagonist Therapeutics Inc. (PTGX) has performed over the last day, week, month and year, over 5 and 10 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | -5.7% | +0.0% | -5.7% | — |
| 5 days | -10.4% | +0.0% | -10.4% | -11.1%Oct 16 |
| 1 month | -9.9% | +0.0% | -9.9% | -11.2%Oct 16 |
| YTD | +47.4% | +0.0% | +47.4% | -18.8%Oct 16 |
| 1 year | +70.0% | +0.0% | +70.0% | -18.8%Oct 2026 |
| 5 years | +33.0% | +0.0% | +33.0%+315.7% | -81.0%Jun 2022 |
| 10 years | +19.6% | +0.0% | +19.6%+500.0% | -85.8%Jun 2022 |
| Since inception (2016) | +26.6% | +0.0% | +26.6%+1000.4% | -85.8%Jun 2022 |
Growth of PTGX#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years+33.0%/year · +315.7%
- 10 years+19.6%/year · +500.0%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in PTGX's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Protagonist Therapeutics Inc.'s 10-year return?
- Over the last 10 years, Protagonist Therapeutics Inc. (PTGX) returned about +19.6% a year annualized (+500.0% cumulative total return).
- What is Protagonist Therapeutics Inc.'s return since inception?
- Since 2016, Protagonist Therapeutics Inc. (PTGX) has compounded at about +26.6% a year — +1000.4% in total.